1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

XIONPROCESS

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2018

Location

Seoul South Korea

Primary Industry

Medical Devices & Equipment

About

Based in Seoul, South Korea and founded in 2018, XIONPROCESS CORP develops alternative diagnostic devices to magnetic resonance imaging (MRI) or positron emission tomography (PET) for Alzheimer's and Parkinson's diseases. The company utilizes AI machine learning technology to analyze and detect abnormalities. The company's revenue is generated by selling its medical devices to hospitals. The company aims to broaden its usage to ordinary people with no cognitive impairment and pets.
Current Investors
Nextdream Angelclub

Request a demo to show more

Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment
Website
www.xionprocess.com
Verticals
Artificial Intelligence
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.